Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ: AGIO · Real-Time Price · USD

35.35

+0.98 (2.85%)

Jul 2, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2019
Medicines for Cellular Metabolism	36.50M	Log In	Log In	Log In	Log In	Upgrade
Medicines for Cellular Metabolism Growth	36.07%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2017 - 2019
United States	36.50M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	36.07%	Log In	Log In	Log In	Log In	Upgrade